RAFAEL HOLDINGS, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$12.00 thousand for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-04-30 was -$3.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-01-31 was -$5.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2022-10-31 was -$4.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2022-07-31 was -$3.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$40.00K, a 190.91% decline from fiscal 2021.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2021 was $44.00K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2023-04-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$8.00K derived: sum of 2 quarters · filed 2023-06-13 | -$12.00K 10-Q · filed 2023-06-13 | -$15.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2023-01-31 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$9.00K 10-Q · filed 2023-03-14 | -$12.00K derived: sum of 3 quarters · filed 2023-03-14 | -$13.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-10-31 | -$4.00K 10-Q · filed 2022-12-13 | -$7.00K derived: sum of 2 quarters · filed 2022-12-13 | -$8.00K derived: sum of 3 quarters · filed 2023-06-13 | -$11.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-07-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$4.00K derived: sum of 2 quarters · filed 2023-06-13 | -$7.00K derived: sum of 3 quarters · filed 2023-06-13 | -$40.00K 10-K · filed 2022-10-31 |
| 2022-04-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$4.00K derived: sum of 2 quarters · filed 2023-06-13 | -$37.00K 10-Q · filed 2023-06-13 | |
| 2022-01-31 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$36.00K 10-Q · filed 2023-03-14 | ||
| 2021-10-31 | -$33.00K 10-Q · filed 2022-12-13 | |||
| 2021-07-31 | $44.00K 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |